SAVENE

Reason for request

Clinical Benefit

Substantial

The actual benefit provided by SAVENE in the treatment of anthracycline extravasation is substantial.

Clinical Added Value

moderate

In light of the absence of treatment alternatives and despite the methodological inadequacies of the studies contained in the file, the Transparency Committee considers that SAVENE provides a moderate improvement in actual benefit (IAB III) in the treatment of anthracycline extravasations.